NCT05558124 2026-02-27CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AMLH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Recruiting18 enrolled
NCT04915612 2026-02-20Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid LeukemiaM.D. Anderson Cancer CenterPhase 1 Completed1 enrolled